Zen-Bio Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Zen-Bio's estimated annual revenue is currently $3.7M per year.(i)
  • Zen-Bio's estimated revenue per employee is $177,143

Employee Data

  • Zen-Bio has 21 Employees.(i)
  • Zen-Bio grew their employee count by 5% last year.

Zen-Bio's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
COOReveal Email/Phone
3
Production ManagerReveal Email/Phone
4
Research AssociateReveal Email/Phone
5
Associate Scientist IIReveal Email/Phone
6
Research AssociateReveal Email/Phone
7
WorkerReveal Email/Phone
8
Executive Dir, Regenerative MedicineReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M637%N/AN/A
#2
$5099.8M32902-4%N/AN/A
#3
$1.7M110%N/AN/A
#4
$0.6M4-56%N/AN/A
#5
N/A157%N/AN/A
#6
$0.9M11-39%N/AN/A
#7
$1.7M90%N/AN/A
#8
$0.6M30%N/AN/A
#9
$4.8M31-6%N/AN/A
#10
$6.4M366%N/AN/A
Add Company

What Is Zen-Bio?

Zen-Bio, Inc. (ZB) is a leading global provider of advanced cell-based solutions and services to the life science, cosmetics, and personal care communities. The company, founded in 1995, was a pioneer in adipose derived stem cells (ASCs) and continues this legacy by providing cutting edge human primary cell culture products and services. Our mission is to provide the highest quality human cell systems, reagents and contract services to our research partners, to develop and commercialize innovative research tools, leverage our expertise through research and development and strategic alliances, and accelerate discovery. Our wide range of cell systems offered include blood derivatives, adipocytes, stem cells, hepatocytes and many other human primary cells types. We specialize in custom cell isolations from just about any tissue type.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$3.7M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.1M2111%N/A
#2
$2.3M21-5%N/A
#3
$3.4M220%N/A
#4
$5.2M22-49%N/A
#5
$4.5M23-4%N/A